Your session is about to expire
← Back to Search
Other
Drug Combination for Fertility Preservation (Ooxyd Trial)
N/A
Recruiting
Research Sponsored by Clinique Ovo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline oxidative stress at the end of ivf controlled ovarian stimulaition
Awards & highlights
Ooxyd Trial Summary
This trial is testing if using a combination of two drugs for fertility preservation may increase the number of eggs retrieved.
Who is the study for?
This trial is for women aged 18-37 who are looking to preserve their fertility for personal or medical reasons. It's not suitable for pregnant or breastfeeding women, those with certain hormonal disorders, advanced endometriosis, unexplained bleeding issues, kidney/liver problems, or allergies to the medications used.Check my eligibility
What is being tested?
The study tests how oxidative stress affects egg quality during fertility preservation. Participants will undergo IVF and take Rekovelle and Menopur to stimulate follicle production. Blood levels of oxidative stress and cf-DNA will be measured; AI tool Magenta assesses oocyte quality non-invasively.See study design
What are the potential side effects?
There are no direct side effects mentioned from measuring oxidative stress or using the AI tool Magenta in this study. However, IVF-related procedures can include bloating, cramping, mood swings and risks associated with egg retrieval.
Ooxyd Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at the end of ivf stimulation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the end of ivf stimulation
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Evaluate the correlation between the oxidative stress and the quality of oocytes
Secondary outcome measures
Assessment of good quality oocytes
Evaluation of oocyte quality by visualization
Oocytes
Ooxyd Trial Design
2Treatment groups
Experimental Treatment
Group I: Social (elective) preservationExperimental Treatment3 Interventions
Group II: Oncology preservationExperimental Treatment3 Interventions
Find a Location
Who is running the clinical trial?
Clinique OvoLead Sponsor
31 Previous Clinical Trials
41,327 Total Patients Enrolled
Ferring PharmaceuticalsIndustry Sponsor
313 Previous Clinical Trials
440,678 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have kidney or liver problems.I am a woman aged 18-37 seeking fertility preservation for personal or cancer-related reasons.My tumor is located in the hypothalamus or pituitary gland.My thyroid or adrenal glands are not functioning properly and are not controlled.I am taking Coenzyme Q10 during my treatment cycle.My ovaries are enlarged for reasons other than polycystic ovarian syndrome.I have not used any hormonal treatments except for thyroid medication during my last menstrual cycle.I have unexplained bleeding related to female reproductive organs.My condition is advanced endometriosis (stage III/IV).
Research Study Groups:
This trial has the following groups:- Group 1: Oncology preservation
- Group 2: Social (elective) preservation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Fertility Preservation Patient Testimony for trial: Trial Name: NCT05372549 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are being administered treatment in this trial?
"The trial requires 180 eligible patients to commence. The study's primary sponsor, Clinique Ovo, will administer the trial across two locations in Canada: their own facility located in Montreal and Ottawa Fertility Centre situated in Ottawa."
Answered by AI
Am I eligible to participate in this trial?
"This experiment is actively seeking 180 individuals aged 18 to 37 for fertility preservation. To be considered, applicants must fall within the given age range and meet either social or oncological qualification standards."
Answered by AI
Does this trial offer participation to individuals aged twenty and over?
"The upper and lower age limits for this medical trial are 37 years old and 18 respectively."
Answered by AI
Is this research endeavor currently looking for participants?
"Confirmed. According to the information provided on clinicaltrials.gov, this medical trial is actively looking for participants since its initial posting date of June 1st 2022 and most recent update from August 3rd 2022. The research requires 180 patients to be recruited at three separate centres."
Answered by AI
Who else is applying?
What state do they live in?
North Carolina
What site did they apply to?
Ottawa Fertility Centre
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
Why did patients apply to this trial?
I am hoping to get pregnant ❤️.
PatientReceived 2+ prior treatments
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger